Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18
NCT02550314Phase 3Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Mar 2015
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of trafermin in tympanic membrane perforation, sponsored by Translational Research Center for Medical Innovation. Started Mar 2015; status: completed.
02
Drugs
trafermin
03
Conditions
tympanic membrane perforation
Beyond the preview
Go deeper on NCT02550314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02550314.